A pregnant woman stands for a portrait in Dallas, Thursday, May 18, 2023. On Friday, Aug. 4, 2023, U.S. health officials approved the first pill, Zurzuvae, specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year. (AP Photo/LM Otero, File)